ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,518,711 | -21.2% | 1,506,237 | -1.8% | 0.00% | – |
Q2 2023 | $5,734,497 | -8.1% | 1,533,288 | -17.7% | 0.00% | – |
Q1 2023 | $6,242,179 | -66.5% | 1,863,337 | -51.9% | 0.00% | -100.0% |
Q4 2022 | $18,640,962 | +72.9% | 3,875,460 | +104.5% | 0.00% | 0.0% |
Q3 2022 | $10,781,000 | -15.8% | 1,894,736 | +5.1% | 0.00% | 0.0% |
Q2 2022 | $12,804,000 | -5.3% | 1,803,368 | -3.7% | 0.00% | 0.0% |
Q1 2022 | $13,516,000 | -35.0% | 1,872,074 | -19.5% | 0.00% | 0.0% |
Q4 2021 | $20,790,000 | -46.2% | 2,325,453 | +110.9% | 0.00% | -50.0% |
Q3 2021 | $38,666,000 | +87.2% | 1,102,852 | +14.7% | 0.00% | +100.0% |
Q2 2021 | $20,659,000 | +17.6% | 961,767 | +238.0% | 0.00% | 0.0% |
Q1 2021 | $17,569,000 | +88.9% | 284,523 | +27.8% | 0.00% | 0.0% |
Q4 2020 | $9,303,000 | – | 222,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
Atom Investors LP | 30,911 | $219,000 | 0.10% |
FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |